Actual economic loss in private damages action

AND · 15usc78j:economic-loss

The private remedy requires economic loss, unlike the core SEC violation. Mere payment of an inflated purchase price does not itself establish the loss identified in Dura.

Exact element source

any manipulative or deceptive device or contrivance
Source: docroot/ir/usc/title15.jsonl#title15_sec78j; Unicode character offsets [907:958] (end exclusive); SHA-256 8ceaded2a57e5b49e22a4766033c8899ebfd730667700a031b8db7f80ea91e32.

Routes and case patterns

Curated routes and observed case patterns
RouteDefinitionMerits instance blocksDistinct merits casesExamples (up to 3 cases per count group)
purchase-price-inflation
provisional; provisional (1 case)
Whether paying an artificially inflated purchase price is by itself an economic loss (Dura).1
Satisfied 0; not satisfied 1; excluded context 0
1

Dura Pharmaceuticals, Inc. v. Broudo — 544 U.S. 336 (2005) · Supreme Court of the United States · 2005 — not · pleaded (15usc78j: author: Astra2 · not independently reviewed) · applied/merits · counted
Pattern: purchase-inflation/spray-device

How courts decided this element

Annotation blocks, including explicitly excluded context
CaseElementHolding and scopePatternExact source quotations
Dura Pharmaceuticals, Inc. v. Broudo — 544 U.S. 336 (2005) · Supreme Court of the United States · 2005 — not · pleaded (15usc78j: author: Astra2 · not independently reviewed)Actual economic loss in private damages actionnot
Counted merits instance
applied / merits

basis: pleaded; count: spray-device claim; subject: count=spray-device claim

Inflation is plaintiffs' asserted injury, hence supports polarity for that allegation; the Court rejects its legal sufficiency. The temporary price drop followed by recovery is counterevidence, not an allegation of lasting loss.
purchase-inflation/spray-device
(6) About eight months later (in November 1998), Dura announced that the FDA would not approve Dura’s new asthmatic spray device. Id., at 110a.
Source: docroot/ir/caselaw/us_544.jsonl#/us/544/0336-01; Unicode character offsets [2000:2143] (end exclusive); SHA-256 d3babb1f78e697e8ce54ae719d486a42c4f4c9380530b739819d197987015075.

Evidence kind: fact; polarity: cuts-against; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

(7) The next day Dura’s share price temporarily fell but almost fully recovered within one week. Id., at 156a.
Source: docroot/ir/caselaw/us_544.jsonl#/us/544/0336-01; Unicode character offsets [2144:2254] (end exclusive); SHA-256 d3babb1f78e697e8ce54ae719d486a42c4f4c9380530b739819d197987015075.

Evidence kind: fact; polarity: cuts-against; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

Most importantly, the complaint says the following (and nothing significantly more than the following) about economic losses attributable to the spray device misstatement: “In reliance on the integrity of the market, [the plaintiffs] . . . paid artificially inflated prices for Dura securities” and the plaintiffs suffered “damagefs]” thereby. Id., at 139a (emphasis added).
Source: docroot/ir/caselaw/us_544.jsonl#/us/544/0336-01; Unicode character offsets [2255:2629] (end exclusive); SHA-256 d3babb1f78e697e8ce54ae719d486a42c4f4c9380530b739819d197987015075.

Evidence kind: fact; polarity: supports; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

Normally, in cases such as this one (i. e., fraud-on-the-market cases), an inflated purchase price will not itself constitute or proximately cause the relevant economic loss.
Source: docroot/ir/caselaw/us_544.jsonl#/us/544/0336-01; Unicode character offsets [6860:7034] (end exclusive); SHA-256 d3babb1f78e697e8ce54ae719d486a42c4f4c9380530b739819d197987015075.

Evidence kind: rule; polarity: not recorded; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

For reasons set forth in Part II-A, supra, however, the “artificially inflated purchase price” is not itself a relevant economic loss.
Source: docroot/ir/caselaw/us_544.jsonl#/us/544/0336-01; Unicode character offsets [16499:16633] (end exclusive); SHA-256 d3babb1f78e697e8ce54ae719d486a42c4f4c9380530b739819d197987015075.

Evidence kind: held; polarity: not recorded; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

Court interpretations

interpretation

Normally, in cases such as this one (i. e., fraud-on-the-market cases), an inflated purchase price will not itself constitute or proximately cause the relevant economic loss.

Dura Pharmaceuticals, Inc. v. Broudo — 544 U.S. 336 (2005) · Supreme Court of the United States · 2005 (15usc78j: author: Astra2 · not independently reviewed)

Normally, in cases such as this one (i. e., fraud-on-the-market cases), an inflated purchase price will not itself constitute or proximately cause the relevant economic loss.
Source: docroot/ir/caselaw/us_544.jsonl#/us/544/0336-01; Unicode character offsets [6860:7034] (end exclusive); SHA-256 d3babb1f78e697e8ce54ae719d486a42c4f4c9380530b739819d197987015075.

The private remedy requires economic loss, unlike the core SEC violation. Mere payment of an inflated purchase price does not itself establish the loss identified in Dura.